Sg Americas Securities, LLC Biomarin Pharmaceutical Inc Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 6,270 shares of BMRN stock, worth $397,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,270
Previous 7,404 15.32%
Holding current value
$397,643
Previous $610,000 27.7%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
SELL
$69.02 - $93.84 $78,268 - $106,414
-1,134 Reduced 15.32%
6,270 $441,000
Q2 2024

Jul 12, 2024
SELL
$74.43 - $92.22 $2.09 Million - $2.59 Million
-28,078 Reduced 79.13%
7,404 $610,000
Q1 2024

May 06, 2024
BUY
$83.81 - $99.0 $2.97 Million - $3.51 Million
35,482 New
35,482 $3.1 Million
Q3 2023

Oct 13, 2023
SELL
$85.07 - $94.48 $246,107 - $273,330
-2,893 Reduced 36.85%
4,957 $439,000
Q2 2023

Jul 10, 2023
BUY
$86.68 - $100.3 $426,378 - $493,375
4,919 Added 167.83%
7,850 $680,000
Q1 2023

Apr 28, 2023
SELL
$87.74 - $117.27 $843,532 - $1.13 Million
-9,614 Reduced 76.64%
2,931 $285,000
Q4 2022

Feb 02, 2023
BUY
$80.93 - $108.63 $876,633 - $1.18 Million
10,832 Added 632.34%
12,545 $1.3 Million
Q3 2022

Oct 31, 2022
SELL
$82.16 - $96.94 $2.25 Million - $2.65 Million
-27,364 Reduced 94.11%
1,713 $145,000
Q2 2022

Jul 29, 2022
SELL
$71.48 - $86.85 $2.74 Million - $3.33 Million
-38,363 Reduced 56.88%
29,077 $2.41 Million
Q1 2022

Apr 29, 2022
BUY
$74.28 - $92.69 $2.8 Million - $3.5 Million
37,740 Added 127.07%
67,440 $5.2 Million
Q4 2021

Feb 07, 2022
BUY
$71.72 - $91.47 $2.02 Million - $2.58 Million
28,152 Added 1818.6%
29,700 $2.62 Million
Q3 2021

Nov 01, 2021
SELL
$74.77 - $85.47 $445,105 - $508,802
-5,953 Reduced 79.36%
1,548 $120,000
Q2 2021

Aug 12, 2021
SELL
$75.51 - $84.79 $302,568 - $339,753
-4,007 Reduced 34.82%
7,501 $626,000
Q1 2021

May 13, 2021
SELL
$74.73 - $90.69 $460,037 - $558,287
-6,156 Reduced 34.85%
11,508 $869,000
Q4 2020

Feb 04, 2021
SELL
$72.61 - $90.2 $3.18 Million - $3.95 Million
-43,792 Reduced 71.26%
17,664 $1.55 Million
Q3 2020

Nov 09, 2020
SELL
$71.87 - $131.03 $1.88 Million - $3.42 Million
-26,112 Reduced 29.82%
61,456 $4.68 Million
Q2 2020

Jul 20, 2020
BUY
$79.55 - $124.22 $6.08 Million - $9.5 Million
76,441 Added 686.99%
87,568 $10.8 Million
Q1 2020

Apr 30, 2020
SELL
$71.37 - $96.85 $227,242 - $308,370
-3,184 Reduced 22.25%
11,127 $940,000
Q4 2019

Jan 28, 2020
SELL
$64.27 - $86.37 $5.34 Million - $7.18 Million
-83,111 Reduced 85.31%
14,311 $1.21 Million
Q3 2019

Nov 04, 2019
BUY
$67.4 - $85.11 $5.57 Million - $7.04 Million
82,669 Added 560.35%
97,422 $6.57 Million
Q2 2019

Jul 29, 2019
BUY
$80.35 - $93.9 $74,805 - $87,420
931 Added 6.74%
14,753 $1.26 Million
Q1 2019

Apr 29, 2019
BUY
$84.2 - $98.62 $1.16 Million - $1.36 Million
13,822 New
13,822 $1.23 Million
Q4 2018

Feb 01, 2019
SELL
$80.14 - $106.07 $2.25 Million - $2.98 Million
-28,094 Closed
0 $0
Q3 2018

Nov 06, 2018
BUY
$93.92 - $105.72 $1.78 Million - $2.01 Million
18,988 Added 208.52%
28,094 $2.72 Million
Q2 2018

Aug 07, 2018
BUY
$76.01 - $99.03 $100,865 - $131,412
1,327 Added 17.06%
9,106 $858,000
Q1 2018

May 03, 2018
BUY
$77.67 - $92.63 $79,611 - $94,945
1,025 Added 15.18%
7,779 $631,000
Q4 2017

Jan 24, 2018
BUY
$80.76 - $95.13 $417,367 - $491,631
5,168 Added 325.85%
6,754 $602,000
Q3 2017

Nov 07, 2017
BUY
$80.6 - $94.95 $127,831 - $150,590
1,586
1,586 $148,000

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email